Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
3/28/2024 | $13.00 → $13.50 | Buy | Needham |
3/13/2024 | Mkt Perform → Outperform | William Blair | |
2/16/2024 | $9.00 → $12.00 | Neutral → Buy | BofA Securities |
7/19/2023 | $11.00 | Buy | Craig Hallum |
8/12/2022 | $6.50 → $6.00 | Buy → Neutral | BofA Securities |
8/12/2022 | Outperform → Mkt Perform | William Blair | |
2/24/2022 | $10.50 | Overweight | JP Morgan |
2/11/2022 | $10.50 | Buy | Deutsche Bank |
144 - Cellebrite DI Ltd. (0001854587) (Subject)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously
William Blair upgraded Cellebrite DI from Mkt Perform to Outperform
BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously
Third-quarter 2024 revenue of $106.9 million exceeds $100 million quarterly revenue milestone for the first time in Company history Third-quarter 2024 revenue increased 27% year-over-year primarily due to 27% growth in subscription revenue ARR of $370.8 million, up 26% year-over-year Third-quarter 2024 adjusted EBITDA of $31.3 million, 29.3% adjusted EBITDA margin Company increases 2024 outlook for revenue and adjusted EBITDA, and raises the low end of the 2024 ARR target range TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announ
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2024 financial results before market open on Wednesday, November 6, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the third quarter of 2024 and discuss its 2024 outlook. Relevant details include: Date:Wednesday, November 6, 2024Time:8:30 a.m. ETCall-In Number:203-518-9766Conference ID: CLBTQ324Event URL:https://investors.cellebrite.com/events/event-det
Revenue of $95.7 million, 25% year-over-year increase primarily due to27% growth in subscription revenue;ARR of $345.9 million, up 26% year-over-year;Adjusted EBITDA of $21.6 million, 22.6% adjusted EBITDA margin;Company increases 2024 outlook for revenue and adjusted EBITDA, and raises midpoint for ARR TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Intelligence ("DI") solutions for the public and private sectors, today announced financial results for the three and six months ending June 30, 2024. "Our outstanding second-quarter 2024 performance was highlighted by significant strategic progress and strong
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, and Relativity, a global legal technology company, announced today the general availability of the integration of Cellebrite's mobile collection solutions, Endpoint Inspector and Endpoint Mobile Now, into the RelativityOne platform. The need for mobile collection in legal processes continues to grow and this new solution makes the management of mobile data faster, more accessible and highly efficient. An Advanced Access (AA) program was conducted in July 2024 with a group of customers and
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to
Third-quarter 2024 revenue of $106.9 million exceeds $100 million quarterly revenue milestone for the first time in Company history Third-quarter 2024 revenue increased 27% year-over-year primarily due to 27% growth in subscription revenue ARR of $370.8 million, up 26% year-over-year Third-quarter 2024 adjusted EBITDA of $31.3 million, 29.3% adjusted EBITDA margin Company increases 2024 outlook for revenue and adjusted EBITDA, and raises the low end of the 2024 ARR target range TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announ
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)
The Federal Bureau of Investigation (FBI) has reportedly used an unreleased technology from Israel-based digital intelligence company Cellebrite (NASDAQ:CLBT) to gain access to the phone of the individual who targeted former President Donald Trump. What Happened: After the FBI faced difficulties unlocking the phone of the shooter, identified as Thomas Matthew Crooks, they turned to Cellebrite for assistance. Despite having a license for Cellebrite’s software, the FBI’s Pittsburgh bureau was unable to bypass the passcode on Crooks’ newer Samsung model phone, which runs on Android’s operating system. Upon reaching out to Cellebrite’s team, the FBI received additional technical support a
JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $12 to $14.
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13.5 to $14.
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today that Troy Richardson has joined its board of directors, effective August 13, 2024. Mr. Richardson is a seasoned technology executive with more than 30 years of experience in leading, scaling and transforming global organizations. He currently serves on the Unisys Corporation (NYSE:UIS) Board of Directors and previously served as a Director of the Board for Carestream Dental. Mr. Richardson was president of the Digital Thread group at PTC Inc. (NASDAQ:PTC) from 2021 until 2022
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the appointment of Sigalit Shavit as Chief Information Officer (CIO) who begins her role today, August 1, 2024. Shavit joins the Company's Leadership Team, bringing with her more than 30 years of experience to Cellebrite's information technology and security team. In this newly established position that reports to CEO Yossi Carmil, Shavit will play a pivotal role in scaling the Company's ability to innovate and support customers as they strive to continue accelerating justice a